Found: 33
Select item for more details and to access through your institution.
A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case–Control Study.
- Published in:
- Applied Health Economics & Health Policy, 2019, v. 17, n. 3, p. 381, doi. 10.1007/s40258-018-0451-1
- By:
- Publication type:
- Article
Short-term outcomes associated with temozolomide or PCV chemotherapy for 1p/19q-codeleted WHO grade 3 oligodendrogliomas: A national evaluation.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 3, p. 201, doi. 10.1093/nop/npac004
- By:
- Publication type:
- Article
Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 4, p. 619, doi. 10.1007/s10637-017-0531-3
- By:
- Publication type:
- Article
Quantification of aneuploidy in targeted sequencing data using ASCETS.
- Published in:
- Bioinformatics, 2021, v. 37, n. 16, p. 2461, doi. 10.1093/bioinformatics/btaa980
- By:
- Publication type:
- Article
Acute Frontal Love Dysfunction Following Prefrontal Lobe Frequency Repetitive Transcranial Magnetic Stimulation in a Patient with Treatment-Resistant Depression.
- Published in:
- Frontiers in Psychiatry, 2017, v. 8, p. 1, doi. 10.3389/fpsyt.2017.00096
- By:
- Publication type:
- Article
Severity, timeline, and management of complications after stereotactic brain biopsy.
- Published in:
- Journal of Neurosurgery, 2022, v. 136, n. 3, p. 867, doi. 10.3171/2021.3.JNS21134
- By:
- Publication type:
- Article
Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome.
- Published in:
- Acta Neuropathologica Communications, 2018, v. 6, n. 1, p. N.PAG, doi. 10.1186/s40478-018-0594-1
- By:
- Publication type:
- Article
Microfluidic active loading of single cells enables analysis of complex clinical specimens.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-07283-x
- By:
- Publication type:
- Article
Hippocampal and neocortical BRAF mutant non‐expansive lesions in focal epilepsies.
- Published in:
- Neuropathology & Applied Neurobiology, 2023, v. 49, n. 5, p. 1, doi. 10.1111/nan.12937
- By:
- Publication type:
- Article
A threshold for mitotic activity and post‐surgical residual volume defines distinct prognostic groups for astrocytoma IDH‐mutant.
- Published in:
- Neuropathology & Applied Neurobiology, 2023, v. 49, n. 4, p. 1, doi. 10.1111/nan.12928
- By:
- Publication type:
- Article
PATH-16. MOLECULAR PATHOLOGY AND CLINICAL CHARACTERISTICS OF MMR DEFICIENCY (MMRd) IN DIFFUSE GLIOMAS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi161, doi. 10.1093/neuonc/noy148.672
- By:
- Publication type:
- Article
INNV-13. ALLELE: A CONSORTIUM FOR PROSPECTIVE GENOMICS AND FUNCTIONAL DIAGNOSTICS TO GUIDE PATIENT CARE AND TRIAL ANALYSIS IN NEWLY-DIAGNOSED GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi140, doi. 10.1093/neuonc/noy148.587
- By:
- Publication type:
- Article
IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 5, p. 716, doi. 10.1093/neuonc/noy014
- By:
- Publication type:
- Article
DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Exploring the mechanism of 18F‐fluorodopa uptake in recurrent high‐grade gliomas: A comprehensive histomolecular‐positron emission tomography analysis.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 1, p. 1, doi. 10.1111/ene.16093
- By:
- Publication type:
- Article
A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation.
- Published in:
- Acta Neuropathologica, 2024, v. 147, n. 1, p. 1, doi. 10.1007/s00401-023-02651-4
- By:
- Publication type:
- Article
Successful treatment of multiple intracranial meningiomas with the antiprogesterone receptor agent mifepristone (RU486).
- Published in:
- Acta Neurochirurgica, 2014, v. 156, n. 10, p. 1831, doi. 10.1007/s00701-014-2188-4
- By:
- Publication type:
- Article
Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00331-2
- By:
- Publication type:
- Article
A Predictive Clinical-Radiomics Nomogram for Survival Prediction of Glioblastoma Using MRI.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 11, p. 2043, doi. 10.3390/diagnostics11112043
- By:
- Publication type:
- Article
Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 7, p. 1263, doi. 10.3390/diagnostics11071263
- By:
- Publication type:
- Article
IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives.
- Published in:
- Journal of Blood Medicine, 2016, v. 7, p. 171, doi. 10.2147/JBM.S70716
- By:
- Publication type:
- Article
Correction to: Antibiotic prescriptions and risk factors for antimicrobial resistance in patients hospitalized with urinary tract infection: a matched case-control study using the French health insurance database (SNDS).
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: Antibiotic prescriptions and risk factors for antimicrobial resistance in patients hospitalized with urinary tract infection: a matched case-control study using the French health insurance database (SNDS).
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Antibiotic prescriptions and risk factors for antimicrobial resistance in patients hospitalized with urinary tract infection: a matched case-control study using the French health insurance database (SNDS).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesion.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 1, p. 159, doi. 10.1007/s11060-022-04129-x
- By:
- Publication type:
- Article
Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 140, n. 2, p. 317, doi. 10.1007/s11060-018-2955-9
- By:
- Publication type:
- Article
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 2, p. 307, doi. 10.1007/s11060-015-1802-5
- By:
- Publication type:
- Article
Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1763, doi. 10.1634/theoncologist.2020-0258
- By:
- Publication type:
- Article
Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen‐Activated Protein Kinase Pathway Alterations.
- Published in:
- Oncologist, 2019, v. 24, n. 12, p. 1584, doi. 10.1634/theoncologist.2019-0223
- By:
- Publication type:
- Article
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1805, doi. 10.1093/neuonc/noae107
- By:
- Publication type:
- Article
EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 813, doi. 10.1093/neuonc/noad008
- By:
- Publication type:
- Article
Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1140, doi. 10.1093/neuonc/noab282
- By:
- Publication type:
- Article
Progressive multifocal leukoencephalopathy after first-line radiotherapy and temozolomide for glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 497, doi. 10.1093/neuonc/noab306
- By:
- Publication type:
- Article